EmailLinkedIn
Symetis2022-02-09T19:20:25+00:00

Project Description

Symetis

CEO
Jacques Essinger

Sector
Medical Devices

Location
Ecublens, Switzerland

Investment Stage
Growth

Investment Status
Exit

Year Invested
2016

Endeavour Vision Deal Team
Damien Tappy
Dominik Ellenrieder

Back to all companies

Symetis

Symetis specialises in the development, manufacturing and marketing of next-generation percutaneous heart valve replacement solutions for the treatment of severe cardiac valve conditions.

Symetis was acquired by Boston Scientific in 2017.

Read More

Our Mission

‘To improve the standard of care for millions of people and streamline healthcare delivery by investing in transformative healthcare technologies’

Contact

Endeavour Vision Ltd.
Rue de la Confédération 7,
1204, Geneva
Switzerland

+41 22 544 6000

Click here to get in touch

Quick Links

About
Team
Portfolio
Financing
ESG & Impact
News
Contact
FAQ

Newsletter

Sign up to receive our latest news
Sign Up
We use cookies to improve your experience. By using this site, you are accepting our privacy and cookie policy. OK
Go to Top